Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Other Non-Current Liabilities (2016 - 2025)

Traws Pharma's Other Non-Current Liabilities history spans 11 years, with the latest figure at $100000.0 for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $100000.0 for Q4 2025, down 99.76% from a year ago — trailing twelve months through Dec 2025 was $100000.0 (down 99.76% YoY), and the annual figure for FY2025 was $100000.0, down 99.76%.
  • Other Non-Current Liabilities for Q4 2025 was $100000.0 at Traws Pharma, up from $11000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $42.5 million in Q4 2024 to a low of $8000.0 in Q2 2025.
  • The 3-year median for Other Non-Current Liabilities is $154000.0 (2025), against an average of $6.3 million.
  • The sharpest move saw Other Non-Current Liabilities skyrocketed 261.36% in 2021, then plummeted 99.76% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $530000.0 in 2021, then skyrocketed by 7917.74% to $42.5 million in 2024, then plummeted by 99.76% to $100000.0 in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $100000.0, $11000.0, and $8000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.